XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Revenues from Contracts with Customers
 9 Months Ended
Mar. 31, 2021
Revenue from Contract with Customer [Abstract]  
Revenues from Contracts with Customers REVENUES FROM CONTRACTS WITH CUSTOMERS
Disaggregation of Revenue from Contracts with Customers—The disaggregation of revenue by segment and product is depicted for the periods presented below, and is consistent with how the Company evaluates its financial performance:

Three Months Ended March 31,Nine Months Ended March 31,
(in thousands)2021202020212020
Senior:
Commission revenue:
Medicare advantage$181,040 $86,396 $493,745 $220,536 
Medicare supplement2,981 13,831 23,716 27,284 
Prescription drug plan449 355 2,166 2,391 
Dental, vision, and health4,671 2,450 13,041 5,674 
Other commission revenue619 221 1,822 380 
Total commission revenue189,760 103,253 534,490 256,265 
Production bonus and other revenue25,840 4,098 69,819 17,543 
Total Senior revenue215,600 107,351 604,309 273,808 
Life:
Commission revenue:
Core19,604 18,042 58,771 55,745 
Final expense20,625 6,596 48,641 13,480 
Ancillary1,213 604 2,180 1,859 
Total commission revenue41,442 25,242 109,592 71,084 
Production bonus and other revenue4,958 5,714 16,006 16,459 
Total Life revenue46,400 30,956 125,598 87,543 
Auto & Home:
Total commission revenue5,910 9,105 21,014 26,921 
Production bonus and other revenue1,063 1,337 2,738 2,140 
Total Auto & Home revenue6,973 10,442 23,752 29,061 
Eliminations:
Total commission revenue(319)(145)(784)(344)
Production bonus and other revenue(1,731)— (3,509)— 
Total Elimination revenue(2,050)(145)(4,293)(344)
Total commission revenue236,793 137,455 664,312 353,926 
Total production bonus and other revenue30,130 11,149 85,054 36,142 
Total revenue$266,923 $148,604 $749,366 $390,068 
Contract Balances—After a policy is sold, the Company has no material additional or recurring obligations to the policyholder or the insurance carrier. As such, there are no contract liabilities recorded in the condensed consolidated balance sheets. As there is no activity in the contract asset balances other than the movement over time between long-term and short-term commissions receivable and accounts receivable as the policy is renewed, a separate roll forward other than what is shown on the condensed consolidated balance sheets is not relevant. Cumulative revenue catch-up adjustments related to changes in the estimates of transaction prices were not material for the three and nine months ended March 31, 2021 and 2020.

Production Bonuses and Other—During the nine months ended March 31, 2021, the Company received advance payments of fiscal year 2021 marketing development funds, which will be amortized over the course of the year based on policies sold. As of March 31, 2021, there was an unamortized balance remaining of $7.8 million recorded in other current liabilities in the condensed consolidated balance sheet.